Drug Shortage Report for ATROPINE SULFATE INJECTION

Last updated on 2021-10-18 History
Report ID 146183
Drug Identification Number 02426269
Brand name ATROPINE SULFATE INJECTION
Common or Proper name Atropine Sulfate Injection
Company Name LABORATOIRE AGUETTANT
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 0.5 mg/5mL pre-filled syringe. 10 syringes per carton.
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-10-08
Actual start date
Estimated end date 2021-10-22
Actual end date 2021-10-18
Shortage status Resolved
Updated date 2021-10-18
Company comments Unanticipated heavy demand increase for drug.
Health Canada comments
Tier 3 Status No
Contact Address 1, RUE ALEXANDER FLEMING
LYON, RHÔNE
FRANCE 69007
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-10-18 French Compare
v5 2021-10-18 English Compare
v4 2021-10-09 English Compare
v3 2021-09-24 French Compare
v2 2021-09-24 English Compare
v1 2021-09-24 English Compare

Showing 1 to 6 of 6